Gail  Boudreaux net worth and biography

Gail Boudreaux Biography and Net Worth

President, CEO & Director of Elevance Health
Gail Boudreaux serves as president and chief executive officer at Elevance Health, where she leads the company in improving lives and communities, simplifying healthcare, and building trust with customers. Regarded for her ability to skillfully scale multi-billion-dollar businesses, Boudreaux leverages her more than three decades of healthcare industry experience to helm one of America’s largest health companies.

What is Gail Boudreaux's net worth?

The estimated net worth of Gail Boudreaux is at least $46.37 million as of July 22nd, 2024. Ms. Boudreaux owns 126,709 shares of Elevance Health stock worth more than $46,370,426 as of December 21st. This net worth estimate does not reflect any other investments that Ms. Boudreaux may own. Additionally, Ms. Boudreaux receives an annual salary of $6,090,000.00 as President, CEO & Director at Elevance Health. Learn More about Gail Boudreaux's net worth.

How old is Gail Boudreaux?

Ms. Boudreaux is currently 63 years old. There are 5 older executives and no younger executives at Elevance Health. Learn More on Gail Boudreaux's age.

What is Gail Boudreaux's salary?

As the President, CEO & Director of Elevance Health, Inc., Ms. Boudreaux earns $6,090,000.00 per year. Learn More on Gail Boudreaux's salary.

How do I contact Gail Boudreaux?

The corporate mailing address for Ms. Boudreaux and other Elevance Health executives is 220 VIRGINIA AVENUE, INDIANAPOLIS IN, 46204. Elevance Health can also be reached via phone at (800) 331-1476 and via email at [email protected]. Learn More on Gail Boudreaux's contact information.

Has Gail Boudreaux been buying or selling shares of Elevance Health?

Gail Boudreaux has not been actively trading shares of Elevance Health during the last quarter. Most recently, Gail Boudreaux sold 34,000 shares of the business's stock in a transaction on Monday, July 22nd. The shares were sold at an average price of $500.98, for a transaction totalling $17,033,320.00. Following the completion of the sale, the chief executive officer now directly owns 126,709 shares of the company's stock, valued at $63,478,674.82. Learn More on Gail Boudreaux's trading history.

Who are Elevance Health's active insiders?

Elevance Health's insider roster includes Gail Boudreaux (President, CEO & Director), Robert Dixon, Jr. (Director), John Gallina (CFO), Brian Griffin (CEO), Peter Haytaian (EVP), Julie Hill (Director), Charles Kendrick, Jr. (EVP), Gloria Mccarthy (EVP), Felicia Norwood (EVP), Ronald Penczek (CAO), Ramiro Peru (Director), Craig Samitt (EVP), Ryan Schneider (Director), Joseph Swedish (Insider), Jose Tomas (EVP), and Thomas Zielinski (EVP). Learn More on Elevance Health's active insiders.

Are insiders buying or selling shares of Elevance Health?

In the last year, insiders at the sold shares 6 times. They sold a total of 57,339 shares worth more than $28,701,403.88. The most recent insider tranaction occured on October, 18th when EVP Charles Morgan Kendrick Jr sold 7,417 shares worth more than $3,205,182.38. Insiders at Elevance Health own 0.4% of the company. Learn More about insider trades at Elevance Health.

Information on this page was last updated on 10/18/2024.

Gail Boudreaux Insider Trading History at Elevance Health

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/22/2024Sell34,000$500.98$17,033,320.00126,709View SEC Filing Icon  
1/30/2020Buy7,600$266.65$2,026,540.0024,556View SEC Filing Icon  
See Full Table

Gail Boudreaux Buying and Selling Activity at Elevance Health

This chart shows Gail Boudreaux's buying and selling at Elevance Health by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Elevance Health Company Overview

Elevance Health logo
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.
Read More

Today's Range

Now: $365.96
Low: $364.86
High: $372.00

50 Day Range

MA: $409.70
Low: $365.96
High: $509.58

2 Week Range

Now: $365.96
Low: $362.21
High: $567.26

Volume

3,438,138 shs

Average Volume

1,252,031 shs

Market Capitalization

$84.87 billion

P/E Ratio

13.34

Dividend Yield

1.78%

Beta

0.83